Pharmaceuticals, Biotechnology and Life Sciences
Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets
Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders
One person has been left brain dead and five others have been hospitalised after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday.
LivaNova said that FDA’s Warning Letter can be resolved without a material impact on financial results.
Glenmark confirms reaching agreement with Roche over patent disputes
Suven Life Sciences Ltd has announced that the grand of one product patent from Canada, one from ARIPO and one from South Korea corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030.
Brooks Laboratories’ new manufacturing unit in Vadodra to kick off production in 3 months
India’s Dr. Reddy’s has re-launched its Esomeprazole Magnesium Delayed-Release Capsules, which is a therapeutic equivalent generic version of Nexium Delayed-Release…